Long-term effects of eradication of Helicobacter pylori on relapse and histology in gastric ulcer patients: A two-year follow-up study

Scandinavian Journal of Gastroenterology

Volumn 39, Issue 11, 2004, Pages 1066-1072

  Befrits, Ragnar ^a   Sjostedt S ^b   Tour, R ^b   Leijonmarck, C E ^b   Hedenborg, L ^b   Backman, M ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

Gastric ulcer; Helicobacter pylori; NSAID

Indexed keywords

ANTIBIOTIC AGENT; CLARITHROMYCIN; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PLACEBO;

ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; BACTERIUM CULTURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ERADICATION THERAPY; FEMALE; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INTERMETHOD COMPARISON; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; REMISSION; SERODIAGNOSIS; SIDE EFFECT; STOMACH ULCER;

ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ENDOSCOPY, GASTROINTESTINAL; FEMALE; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; RECURRENCE; STOMACH ULCER;

EID: 8844285225     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365520410007872     Document Type: Article

References (33)

1. Marshall BJ. Helicobacter pylori. Am J Gastroenterol 1994;89 Suppl:116-28.
2. Tytgat GNJ, Lee A, Graham DY, Dixon MF, Rokkas T. The role of infectious agents in peptic ulcer disease. Working team report. Gastroenterol Int 1993;2:76-89.
3. Borody TJ, Grandi S, Andreus P, Jankiewicz E, Ostapowicz N. Helicobacter pylori-negative gastric ulcers. Am J Gastroenterol 1992;87:1403-6.
4. Labenz J, Börsch G. Evidence for the essential role of Helicobacter pylori in gastric ulcer disease. Gut 1994;35:19-22.
5. Befrits R, Granström M, Rylander M, Rubio C. Helicobacter pylori in 205 consecutive endoscopy patients. Scand J Infect Dis 1993;25:185-91.
6. Misiewicz JJ, Tytgat GNJ, Goodwin CS, et al. A new classification of gastritis. Working Party Report 1990. p. 1-10.
7. Sandmark S, Carlsson R, Fausa O, Lundell L. Omeprazole or ranitidine in the treatment of reflux esophagitis. Scand J Gastroenterol 1988;23:625-32.
8. Lind T, Havelund T, Carlsson R, Anker-hansen O, Glise H. Heartburn without esophagitis. Efficacy of omeprazole therapy and features determining therapeutic response. Scand J Gastroenterol 1997;32:974-9.
9. Machin D, Campell M. Statistical tables for the design of clinical trials. Oxford: Blackwell Scientific Publications; 1987.
10. Jyotheeswaran S, Shah A, Jin H, Potter G, Ona F, Chey W. Prevalence of Helicobacter pylori in peptic ulcer patients in Greater Rochester, NY: is empirical triple therapy justified? Am J Gastroenterol 1998;93:574-8.
11. Sugiyama T, Nishikawa K, Komatsu Y, Ishizuka J, Mizushima T, Kumagi A, et al. Attributable risk of H. pylori in peptic ulcer disease. Dig Dis Sci 2001;46:307-10.
12. Lindberg G, Befrits R, Sjöstedt S, Ödman B, Sörngård H, the Stockholm United Study Group for Helicobacter Infection. Two-year follow-up of patients with duodenal ulcer after treatment with omeprazole and amoxicillin/placebo. Gastroenterology 1998;114:A205.
13. Axon A, O'Morain C, Bardhan K, Crowe J, Beattie A, Thompsson R, et al. Randomised double blind controlled study of recurrence of gastric ulcer after treatment for eradication of Helicobacter pylori infection. Br Med J 1997;34:565-9.
14. Van der Hulst R, Rauws E, Köycu B, Keller J, Bruno M, Tussen J, et al. Prevention of ulcer recurrence after eradication of Helicobacter pylori: a prospective long-term follow-up study. Gastroenterology 1997;113:1082-6.
15. Lazzaroni M, Perego M, Bargiggia G, Maconi G, Fiocca R, Solcia E, et al. Helicobacter pylori eradication in the healing and recurrence of benign gastric ulcer: a two-year, double blind, placebo controlled study. Ital J Gastroenterol Hepatol 1997;29:220-7.
16. Malfertheimer P, Bayerdörffer E, Diete U, Gil J, Lind T, Misiuna P, et al. The GU-MACH study: the effect of 1-week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer. Aliment Pharmacol Ther 1999;13:703-12.
17. Meining A, Höchter W, Weingart J, Sommer A, Klann H, Simon T, et al, the Ulcer Study Group, Germany. Double blind trial of omeprazole and amoxicillin in the cure of Helicobacter pylori infection in gastric ulcer patients. Scand J Gastroenterol 1998;33:49-54.
18. Kim N, Oh J, Lee C, Lim C, Won K, Choi W, et al. Effect of eradication of Helicobacter pylori on the benign gastric ulcer recurrence: a 24-month follow-up study. Korean J Int Med 1999;14:9-14.
19. Hawkey CJ. Personal review: Helicobacter pylori, NSAIDs and cognitive dissonance. Aliment Pharmacol Ther 1999;13:693-702.
20. Huang JQ, Sridhar S, Hunt R. Role of Helicobacter infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta analysis. Lancet 2002;359:14-22.
21. Chan KL, To KF, Wu J, et al. Eradication of Helicobacter pylori and the risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial. Lancet 2002;359:9-13.
22. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:1127-31.
23. Nomura A, Stemmerman GN, Chyou PH, Kato L, Perez-Perez GI, Blaser M. Helicobacter pylori and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991;325:1132-6.
24. Forman D, Newell DG, Fullerton F, et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. Br Med J 1991;302:1302-5.
25. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001;49:347-53.
26. Ekström A, Held M, Hansson LE, Engstrand L, Nyrén O. Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroenterology 2001;121:784-91.
27. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-9.
28. Sipponen P, Seppälä K, Äärynen M, Helske T, Kettunen P. Chronic gastritis and gastroduodenal ulcer: a case control study on risk of coexisting duodenal or gastric ulcer in patients with gastritis. Gut 1989;30:922-9.
29. Schultze V, Hackelsberger A, Gunther T, Miehlke S, Roessner A, Malfertheiner P. Differing patterns of Helicobacter pylori gastritis in patients with duodenal, prepyloric, and gastric ulcer. Scand J Gastroenterol 1998;33:137-42.
30. Befrits R, Sjöstedt S, Ödman B, Sörngård H, Lindberg Gthe Stockholm United Study Group for Helicobacter infection. Curing Helicobacter pylori in patients with duodenal ulcer does not provoke gastroesophageal reflux disease. Helicobacter 2000;5:202-5.
31. Sung JJ, Lin SR, Ching JY, Zhou LY, To KF, Wang RT, et al. Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective randomized study. Gastroenterology 2000;119:7-14.
32. Kuipers EJ, Nelis GF, Klinkenberg-Knol EC, Snel P, Goldfein D, Kolkman JJ, et al. Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long-term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial. Gut 2004;53:12-20.
33. Cats A, Meuwissen S, Forman D, Craanen M, Kuipers E. Helicobacter pylori: a true carcinogen. Eur J Gastroenterol Hepatol 1998;10:447-50.